Repository of Research and Investigative Information

Repository of Research and Investigative Information

Baqiyatallah University of Medical Sciences

Protective efficacy of the killed toxoplasma gondii vaccine in Nano-alum adjuvant

(2019) Protective efficacy of the killed toxoplasma gondii vaccine in Nano-alum adjuvant. Journal of Mazandaran University of Medical Sciences. pp. 11-23. ISSN 17359279 (ISSN)

[img] Text
Protective efficacy of the killed toxoplasma gondii vaccine in Nano-alum adjuvant.pdf

Download (880kB)

Official URL: https://www.scopus.com/inward/record.uri?eid=2-s2....

Abstract

Background and purpose: Toxoplasma gondii (T. gondii) as a causative agent of toxoplasmosis, is an obligate intracellular parasite which is excreted by the cat's feces. Efforts have been made for the development of toxoplasmosis vaccine, but none led to developing a vaccine with protective immune response to the parasite. Adjuvants are essential for vaccine formulation to create strong immune responses. As an adjuvant, nanomaterials such as nano-alum, can stimulate both humoral and cellular immune responses. The present report aimed to investigate the protective effects of the alum-based nano-adjuvant formulated in killed T. gondii. Materials and methods: In this experimental study, the vaccine candidates were separately formulated in alum, complete Freund, and nano-alum adjuvants. The BALB/c mice were immunized three times with two-week intervals. To investigate the type of induced immune response, sera were analyzed by ELISA for total IgG, IgG1, and IgG2a isotypes and also IL-4, IFN-γ, TNF-α, and IL-2 cytokines. To evaluate lymphocyte proliferation, BrdU method was performed. Results: Immunization of mice with killed Toxoplasma vaccine formulated with nano-alum adjuvant increased lymphocyte proliferation, TNF-α, IL-4, IL-2, and IFN-γ cytokine responses, total antibodies, as well as IgG1 and IgG2a subtypes compared with those of other experimental groups. Conclusion: Compared with alum-based killed Toxoplasma vaccine, the nano-alum adjuvant could strongly induce cellular and humoral immune responses. © 2019, Mazandaran University of Medical Sciences. All rights reserved.

Item Type: Article
Keywords: Adjuvant ELISA Nano-alum Toxoplasma gondii Vaccine aluminum potassium sulfate gamma interferon immunoglobulin G immunoglobulin G1 immunoglobulin G2 interleukin 2 interleukin 4 nano alum adjuvant Toxoplasma gondii vaccine tumor necrosis factor unclassified drug adjuvant therapy animal experiment antiparasitic therapy Article BrdU assay cytokine release drug formulation enzyme linked immunosorbent assay immune response lymphocyte proliferation mouse nonhuman toxoplasmosis vaccination
Divisions:
Page Range: pp. 11-23
Journal or Publication Title: Journal of Mazandaran University of Medical Sciences
Journal Index: Scopus
Volume: 29
Number: 171
ISSN: 17359279 (ISSN)
Depositing User: مهندس مهدی شریفی
URI: http://eprints.bmsu.ac.ir/id/eprint/521

Actions (login required)

View Item View Item